- FDA established key elements of the DMT310 Phase 3 clinical program and delineated a potential regulatory pathway for approval of DMT310 - -The DMT310 Phase 3 program will consist of two pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results